We also observed that glioma-derived IL-33 results in an increase in p-STAT3 in both glioma cells and Iba1+ stromal cells, with subsequent loss of p-STAT3 within glioma cells deficient for nuclear IL-33 (ΔNLS). The gene discussed is IL33; the disease is central nervous system cancer.